Clinical Trials Logo

Filter by:
NCT ID: NCT04164381 Completed - Stroke Clinical Trials

Robotic Rehabilitation and Cognitive Functions

Start date: November 18, 2019
Phase: N/A
Study type: Interventional

A recent multicenter study of the Fondazione Don Gnocchi (FDG) Robotic Rehabilitation Group (NCT02879279) showed the efficacy of robotic rehabilitation in upper limb motor recovery after stroke using a set of robots and sensor-based devices. In clinical practice, beside sensory-motor deficits, stroke patients often present concomitant cognitive impairments (as attention and memory disorders). The robotic and technological systems used in the above-mentioned study allow training on some cognitive functions such as visual memory, visual-spatial functions and working memory, as well as motor training of the upper limb. The aim of the study is to assess whether cognitive functions, such as visual memory, visual-spatial skills and working memory (evaluated with specific tests) improve after robotic therapy of the upper limb in subacute stroke patients.

NCT ID: NCT04164355 Completed - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg

Start date: July 4, 2020
Phase:
Study type: Observational

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.

NCT ID: NCT04163120 Completed - Clinical trials for Polycystic Ovary Syndrome

Effects of a Ketogenic Diet on PCOS Outcomes

Start date: January 2017
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the effects of a low calorie Mediterranean ketogenic diet on Polycystic Ovary Syndrome (PCOS) related outcomes.

NCT ID: NCT04162197 Completed - Stroke Clinical Trials

Efficacy of End-Effector Robot-Assisted Gait Training Combined With Robotic Balance Training in Subacute Stroke Patients

Start date: November 18, 2019
Phase: N/A
Study type: Interventional

Over the last years, the introduction of robotic technologies in gait rehabilitation of stroke patients has aroused great interest. Some studies have been conducted to evaluate the effects of robot-assisted training compared to conventional gait rehabilitation in patients with subacute stroke but no studies seem to investigate the effects of a combined robotic treatment (gait plus balance). The aim of this study is to evaluate the efficacy of a combined gait and balance robotic rehabilitation compared robotic gait training alone.

NCT ID: NCT04161872 Completed - Hyperuricemia Clinical Trials

Nutraceutical on Hyperuricemia

Start date: October 1, 2018
Phase: Phase 4
Study type: Interventional

The aim of this study will be to evaluate if a nutraceutical containing quercetin, rutin, bromelain and L-carnosine (Uricemin®) can reduce uric acid levels in subjects with values between ≥ 6 and < 7 mg/dl after 3 months of therapy.

NCT ID: NCT04161859 Completed - Hypertension Clinical Trials

Use of Nutraceuticals in Clinical Practice

Start date: May 1, 2017
Phase:
Study type: Observational

The aim of this study will be to evaluate the use of the nutraceutical with cardio-metabolic actions in clinical practice in addition to a Mediterranean diet scheme, normally recommended in the clinic. In particular the study will analyze how much the nutraceutical is prescribed and what are the purposes for which it is used and at what dosages.

NCT ID: NCT04161833 Completed - Breast Cancer Clinical Trials

Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA)

AIA
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

In this phase II, multicenter, self-controlled clinical trial, we will evaluate the safety and efficacy of OPERA® for treating anti-aromate inhibitors (AIs) induced arthralgia. The diagnosis of arthralgia will be based on the NCI-CTCAE v4.0 grade of ≥ 1 , A disorder characterized by a sensation of marked discomfort in a joint, mild pain (grade 1). Arthralgia will be assessed at the enrollment and every two months until the sixth month.

NCT ID: NCT04161586 Completed - Anesthesia, Spinal Clinical Trials

Prilocaine for Spinal Anesthesia in Ambulatory Setting

Start date: January 1, 2011
Phase:
Study type: Observational

The purpose of this study is to retrospectively analyze data from more than 3000 procedures, to better define the safety profile of spinal prilocaine and the incidence of complications and side effects.

NCT ID: NCT04161495 Completed - Clinical trials for Factor VIII Deficiency

A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

XTEND-1
Start date: November 19, 2019
Phase: Phase 3
Study type: Interventional

Primary Objective: - To evaluate the efficacy of BIVV001 as a prophylaxis treatment in prophylaxis treatment arm. Secondary Objectives: - To evaluate the efficacy of BIVV001 as a prophylaxis treatment. - To evaluate the efficacy of BIVV001 in the treatment of bleeding episodes. - To evaluate BIVV001 consumption for the prevention and treatment of bleeding episodes. - To evaluate the effect of BIVV001 prophylaxis on joint health outcomes. - To evaluate the effect of BIVV001 prophylaxis on Quality of Life outcomes. - To evaluate the efficacy of BIVV001 for perioperative management. - To evaluate the safety and tolerability of BIVV001 treatment. - To assess the pharmacokinetics (PK) of BIVV001 based on the 1-stage activated partial thromboplastin time (aPTT) and 2-stage chromogenic coagulation factor VIII (FVIII) activity assays.

NCT ID: NCT04160689 Completed - Bone Loss Clinical Trials

Influence of the Implant Connection on Facial Tissues Maturation

Start date: November 1, 2018
Phase: Phase 4
Study type: Interventional

The substitution of a tooth with a fixture often induces undesired morphological changes, resulting in a deterioration of the aesthetic appearance. The purpose of this study is to compare the soft tissue behavior next to two different implant connections: 5° (group 1) and 35° hexed (group 2), conical, internal with switching platform design after 12 months of functional provisionalization